Trial Profile
Driving Simulation Cross-Over Study of Sedative Effects of Tolperisone Compared to Cyclobenzaprine and Placebo
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2022
Price :
$35
*
At a glance
- Drugs Tolperisone (Primary) ; Cyclobenzaprine
- Indications Back pain; Muscle hypertonia; Muscle spasticity
- Focus Therapeutic Use
- Sponsors Neurana Pharmaceuticals
- 12 May 2020 According to a Neurana Pharmaceuticals Media Release, results from this trial were published in the peer-reviewed Journal of Clinical Pharmacy and Therapeutics.
- 12 May 2020 Results presented in the Neurana Pharmaceuticals Media Release.
- 24 Oct 2018 Results (n=31) presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting